Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab vs Bevacizumab for Diabetic Macular Edema (CADME)
NCT01610557Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- May 2012
- Primary completion
- Feb 2015
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of ranibizumab and bevacizumab in diabetic macular edema (DME), sponsored by National Eye Institute. Started May 2012; status: completed.
02
Drugs
ranibizumabbevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01610557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610557.